Portrait Viktor Boerlin

Chief Medical Officer

Dr. Viktor Boerlin is the Chief Medical Officer at Strekin. Dr. Boerlin worked for over 30 years for Sandoz/Novartis and Hoffmann-La Roche in different positions and therapeutic areas overseeing drug development encompassing Phase 1 to Phase 4 clinical trials.  At Sandoz, he led the Department of Neuroendocrinology in clinical R&D where he was responsible for the clinical sections of seven registration filings. Dr. Boerlin served at Sandoz for 3 years as Medical Director in Japan. After his return to Headquarters, he led the phase 4 activities for somatostatin analogs at Novartis and early development for a new molecule of this class. In 2004, Dr. Boerlin took on a new challenge as medical liaison between clinical, preclinical and partnering for projects in type 2 diabetes at Hoffmann-La Roche. Later he became the clinical leader for development of a novel PPAR α/γ agonist and an SGLT2 inhibitor. Dr. Boerlin obtained his M.D. at Basel University Medical School.

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok